Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Esperion Therapeutics Inc. (ESPR)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Partner Fund Management

Christopher Medlock James

1,555,112 $72,344 -5% 1.37%
2. 2,435,500 $113,299 -2% 1.21%
3.
Bailard Inc

Thomas Bailard

76,200 $3,545 +29% 0.21%
4.
PDT Partners

Peter Muller

64,339 $2,993 0.17%
5.
Pentwater Capital ManagementCALL

Matthew Halbower

155,000 $7,211 0.07%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$35.25 2,500 Officer, Director 78,663 2019-09-06 Filing
$33.42 148 Officer, Director 76,163 2019-09-04 Filing
$34.22 4,852 Officer, Director 76,015 2019-09-04 Filing
$33.78 80,000 Large Shareholder 3,652,964 2019-09-04 Filing
$39.56 5,000 Officer, Director 71,163 2019-08-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$43.62 1,500 Officer 11,092 2019-04-03 Filing
$42.71 6,500 Officer 12,592 2019-04-03 Filing
$45.25 1,700 Director 0 2019-03-19 Filing
$44.66 13,629 Director 1,700 2019-03-19 Filing
$50.06 25,000 Director 548,726 2019-03-12 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 2,679,835 $124,665 25.07%
2. 975,000 $45,357 3.89%
3. 4,057,411 $188,750 3.22%
4. 412,093 $19,171 2.11%
5. 52,826 $2,457 1.21%
News See All